Anti-Rheumatic Drugs - Gabon

Gabon

The Gabonese market for Anti-Rheumatic Drugs market is forecasted to witness a substantial growth in revenue, projected to reach US$1.07m units in 2024.
This market is anticipated to exhibit a steady annual growth rate of 0.00% (CAGR 2024-2029), ultimately leading to a market volume of US$1.07m units by 2029.
It is noteworthy to mention that in a global context, United States is expected to generate the highest revenue, amounting to a staggering US$34,700.00m units in 2024.
Gabon is witnessing a growing demand for innovative anti-rheumatic drugs, as the country's healthcare infrastructure continues to improve.

Key regions: Germany, United States, India, Japan, United Kingdom

Market

Region

Region comparison

Currency

Analyst Opinion

The demand for Anti-Rheumatic Drugs in Gabon has been on the rise in recent years.

Customer preferences: Patients suffering from rheumatoid arthritis and other related conditions are the primary consumers of Anti-Rheumatic Drugs in Gabon. These drugs are prescribed by rheumatologists and general practitioners and are available in both branded and generic forms. Patients in Gabon prefer drugs that are affordable and effective in managing their symptoms.

Trends in the market: The Gabonese government has been taking steps to improve the healthcare system in the country, which has led to an increase in the number of healthcare facilities and medical professionals. This has resulted in greater access to healthcare for the population, including those suffering from rheumatoid arthritis and related conditions. As a result, the demand for Anti-Rheumatic Drugs has been steadily increasing.

Local special circumstances: Gabon is a small country with a population of just over 2 million people. The healthcare system is relatively underdeveloped, and there is a shortage of medical professionals. However, the government has been taking steps to address these issues, and there has been some progress in recent years. The country is also heavily dependent on oil exports, which can impact the availability and affordability of drugs.

Underlying macroeconomic factors: The Gabonese economy has been heavily impacted by the global oil market, which has led to fluctuations in government revenue and spending. The government has been working to diversify the economy and reduce reliance on oil exports, but progress has been slow. In addition, the country has a relatively high poverty rate, which can impact the affordability of healthcare and drugs for the population.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.